𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

✍ Scribed by Sharma, Surendra K.; Balamurugan, Arumugam; Saha, Pradip Kumar; Pandey, Ravindra M.; Mehra, Narinder K.

Book ID
127343569
Publisher
American Thoracic Society
Year
2002
Tongue
English
Weight
64 KB
Volume
166
Category
Article
ISSN
1073-449X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunogenetic risk and protective factor
Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms
✍ Okada, Satoshi ;Kamb, Mary L. ;Pandey, Janardan P. ;Philen, Rossanne M. ;Love, L πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 2 views

## Abstract ## Objective To assess L‐tryptophan (LT) dose, age, sex, and immunogenetic markers as possible risk or protective factors for the development of LT‐associated eosinophilia–myalgia syndrome (EMS) and related clinical findings. ## Methods HLA–DRB1 and DQA1 allele typing and Gm/Km pheno